These results suggest the potential use of MIR4435-2HG and lnc-POLD3-2 as novel sensitive biomarkers for early HCC detection as well as complementary tests in patients with HBV-related HCC who had low or normal levels of serum AFP. The gene discussed is POLD3; the disease is hepatocellular carcinoma.